SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Healthy Extracts Inc. (HYEX) , 前瞻盈利收益率 8.12%.
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 12.3
SharesGrow 综合评分： 22/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — HYEX
估值倍数
P/E (TTM)0.0
前瞻 P/E12.3
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.53
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.28
前瞻 EPS（预估）$0.13
每股账面价值$0.00
每股营收$1.05
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield8.12%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2015 |
$-129.28 |
$115.55K |
$-730.87K |
-632.5% |
| 2016 |
$-537.27 |
$162.75K |
$-3.37M |
-2071.2% |
| 2017 |
$-158.17 |
$128.11K |
$-3.56M |
-2780.6% |
| 2018 |
$-145.40 |
$67.13K |
$-3.33M |
-4959.7% |
| 2019 |
$0.69 |
$748.38K |
$632.78K |
84.6% |
| 2020 |
$-1.34 |
$1.28M |
$-2.65M |
-207.5% |
| 2021 |
$-0.77 |
$1.47M |
$-2.04M |
-139.1% |
| 2022 |
$-0.35 |
$2.25M |
$-989.96K |
-44% |
| 2023 |
$-0.85 |
$2.49M |
$-2.47M |
-99.5% |
| 2024 |
$-0.28 |
$3.11M |
$-840.67K |
-27% |
